在线国产一区二区_成人黄色片在线观看_国产成人免费_日韩精品免费在线视频_亚洲精品美女久久_欧美一级免费在线观看

US EUROPE AFRICA ASIA 中文
Business / Baby formula

China's mums key to Nestle baby milk deal

(Agencies) Updated: 2012-04-25 11:19

LONDON/BEIJING - The rise of the middle-class Chinese working mothers helps explain why Nestle paid nearly $12 billion for Pfizer's baby food business and could leave rivals scrambling to catch up.

Across emerging markets, nowhere more than in China, women are increasingly keeping jobs after having children -- a big driving force behind 10 percent annual growth in the $30 billion a year baby food industry.

Foreign labels such as SMA, Promil and S-26 Gold, which Nestle will get with the Pfizer deal, have a definite edge. Nestle's products include Nan, Gerber, Lactogen and Nestogen, but are less well known in China.

Baby milk was the foundation of the world's biggest food company, established in 1866 when German pharmacist Henri Nestle introduced a substitute for mothers who could not breast-feed.

Paying more for the Pfizer unit than the $10 billion that analysts had expected, Nestle trumped a bid from Danone and Mead Johnson.

The Pfizer nutrition business has 85 percent of its sales in emerging markets, and a quarter of sales in China.

Fuelled by 16 million new births a year, annual growth rates for China's baby formula market have been as high as 20 percent over the last five years. The market is forecast to double to $16 billion by 2016.

"The key strategic attraction of the deal in our view is Pfizer's No 5 position in the Chinese infant formula market where despite being global No 1 player in infant formula, Nestle has a relatively weak presence," said analyst Robert Dickinson at brokers Citi.

The Swiss giant is already market leader in milk formula in Latin America, Africa and the Middle East. This brings it the No 1 spot in Asia with its presence outside China counted too.

Globally, Nestle's baby food market share will rise to 25 percent from 19 percent - although this is likely to fall slightly after sell-offs to ensure regulatory clearance. Mead has 16 percent, Danone 14 percent and Abbott Laboratories 12 percent.

Few options for competitors

The Nestle-Pfizer business in China would only have a combined 12 percent market share behind Mead's leading 16 percent and Danone on 14 percent, but that would still be a rise from 10th place and there may be room for expansion.

Analysts looking at China expect the number of middle class households to double to 100 million by 2015.

Hot Topics

Editor's Picks
...
主站蜘蛛池模板: 日韩精品免费在线观看 | 成人黄色录像 | 欧美一级二级三级 | 久久久午夜精品 | 538精品视频 | 五月天婷婷基地 | 91porn在线 | 久久精品网 | 北岛玲在线 | 日韩欧美在线播放 | 可以看毛片的网站 | 日韩中文字幕在线观看 | 五月天婷婷综合网 | 久热国产精品 | 成年人免费看片 | 亚洲黄色片 | 成人在线视频观看 | 做爰xxxⅹ性生交 | 国产一区久久 | 亚洲一区二区av | 欧美日韩第一区 | 日韩欧美精品一区 | 欧美日韩免费一区二区三区 | 又色又爽又黄18网站 | 成人免费看片在线观看 | 欧美日韩久久 | 日韩中文字幕第一页 | 欧美国产在线观看 | 美利坚合众国av | 欧美一级特黄aa大片 | 91久久久久 | 黄色片网站在线观看 | 久久免费国产 | 国产欧美日韩在线观看 | 免费看黄色av | 成人在线观看视频网站 | 日本黄色三级视频 | 天天有av | 亚洲精品一区二区三区在线 | 日韩精品中文字幕在线观看 | 欧美视频久久 |